2011LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)Open access

Maldi-imaging for proteomics of protease inhibitors

J. Bromsoms, Stephen J. Trejo, Jana Alonso Lorenzo, Patricia Marín‐García, José M. Bautista, Francesc Avilés

Open full text 0 citations

Abstract

MALDI-imaging mass spectrometry (MALDI-IMS) is a novel experimental approach to visualize the distribution of biomolecules on tissue sections [1]. Proteins, peptides, lipids and metabolites can be analyzed in a selective and/or highthroughput manner. The application of IMS allows acquisition of protein and peptide profiles, biomarker discovery, biomarker localization, tissue classification or cancer diagnosis and prognosis [1,2]. In this study we report the distribution of protease inhibitors in several mouse tissues, after intraperitoneal injection.

About this research paper

What this paper is about

MALDI-imaging mass spectrometry (MALDI-IMS) is a novel experimental approach to visualize the distribution of biomolecules on tissue sections [1]. Proteins, peptides, lipids and metabolites can be analyzed in a selective and/or highthroughput manner. The application of IMS allows acquisition of protein and peptide profiles, biomarker discovery, biomarker localization, tissue classification or cancer diagnosis and prognosis [1,2]. In this study we report the distribution of protease inhibitors in several mouse tissues, after intraperitoneal injection.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

MALDI-imaging mass spectrometry (MALDI-IMS) is a novel experimental approach to visualize the distribution of biomolecules on tissue sections [1]. Proteins, peptides, lipids and metabolites can be analyzed in a selective and/or highthroughput manner. The application of IMS allows acquisition of protein and peptide profiles, biomarker discovery, biomarker localization, tissue classification or cancer diagnosis and prognosis [1,2]. In this study we report the distribution of protease inhibitors in several mouse tissues, after intraperitoneal injection.

Key concepts: Proteomics, Protease, Biomarker discovery, Biomarker, Mass spectrometry imaging, Chemistry, Biomolecule, Peptide

Related papers

Back to paper searchBrowse research topicsOriginal source
Maldi-imaging for proteomics of protease inhibitors — Research Paper | ScholarLens